Cargando…

Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses

BACKGROUND: Cardiac troponin-I assays have been validated in horses.’High-sensitivity’ cardiac troponin assays are now the standard in human cardiology. Objective: Appropriately validate the’high-sensitivity’ cardiac Troponin-T (hscTnT) assay for clinical use in horses, establish reference intervals...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, E., Seiden-Long, I., Massie, S., Passante, S., Leguillette, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906598/
https://www.ncbi.nlm.nih.gov/pubmed/27296016
http://dx.doi.org/10.1186/s12917-016-0737-1
_version_ 1782437438250024960
author Shields, E.
Seiden-Long, I.
Massie, S.
Passante, S.
Leguillette, R.
author_facet Shields, E.
Seiden-Long, I.
Massie, S.
Passante, S.
Leguillette, R.
author_sort Shields, E.
collection PubMed
description BACKGROUND: Cardiac troponin-I assays have been validated in horses.’High-sensitivity’ cardiac troponin assays are now the standard in human cardiology. Objective: Appropriately validate the’high-sensitivity’ cardiac Troponin-T (hscTnT) assay for clinical use in horses, establish reference intervals, determine the biological variation, and demonstrate assay utility in selected clinical cases. Methods: Analytical validation of the Roche hscTnT assay included within- and between-run precision, linear dose response, limit of quantitation (LoQ), stability, and comparison with cTn-I (iSTAT). Reference intervals and biological variation were determined using adult, healthy, Non-Competition Horses (N = 125) and Racing-Thoroughbreds (N = 178). HscTnT levels were measured in two horses with cardiac pathology. RESULTS: The hscTnT demonstrates acceptable within-run (L1 = 6.5 ng/L, CV 14.9 %, L2 = 10.1 ng/L, CV 8.7 %, L3 = 15.3 ng/L, CV 5.4 %) and between-run precision (L1 = 12.2 ng/L, CV 8.4 %, L2 = 57.0 ng/L, CV 8.4 %, L3 = 256.0 ng/L, CV 9.0 %). The assay was linear from 3 to 391 ng/L. The LoQ was validated at 3 ng/L. Samples demonstrated insignificant decay over freeze-thaw cycle. Comparison with cTnI assay showed excellent correlation (range: 8.0–3535.0 ng/L, R(2) = 0.9996). Reference intervals: The upper 95(th) and 99(th) percentile of the hscTnT population distribution were 6.8 and 16.2 ng/L in Non-Competition Horses, and 14.0 and 23.2 ng/L in Racing-Thoroughbreds. Between-breed, diurnal effect, and between-day variation was below LoQ. Two clinical cases with presumed cardiac pathology had hscTnT levels of 220.9 ng/L and 5723.0 ng/L. CONCLUSIONS: This benchmark study is the first to comply with CLSI guidelines, thus further establishing the performance characteristics of the hscTnT assay, and reference intervals in healthy horses. Two clinical cases demonstrated further the clinical utility of the assay.
format Online
Article
Text
id pubmed-4906598
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49065982016-06-15 Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses Shields, E. Seiden-Long, I. Massie, S. Passante, S. Leguillette, R. BMC Vet Res Research Article BACKGROUND: Cardiac troponin-I assays have been validated in horses.’High-sensitivity’ cardiac troponin assays are now the standard in human cardiology. Objective: Appropriately validate the’high-sensitivity’ cardiac Troponin-T (hscTnT) assay for clinical use in horses, establish reference intervals, determine the biological variation, and demonstrate assay utility in selected clinical cases. Methods: Analytical validation of the Roche hscTnT assay included within- and between-run precision, linear dose response, limit of quantitation (LoQ), stability, and comparison with cTn-I (iSTAT). Reference intervals and biological variation were determined using adult, healthy, Non-Competition Horses (N = 125) and Racing-Thoroughbreds (N = 178). HscTnT levels were measured in two horses with cardiac pathology. RESULTS: The hscTnT demonstrates acceptable within-run (L1 = 6.5 ng/L, CV 14.9 %, L2 = 10.1 ng/L, CV 8.7 %, L3 = 15.3 ng/L, CV 5.4 %) and between-run precision (L1 = 12.2 ng/L, CV 8.4 %, L2 = 57.0 ng/L, CV 8.4 %, L3 = 256.0 ng/L, CV 9.0 %). The assay was linear from 3 to 391 ng/L. The LoQ was validated at 3 ng/L. Samples demonstrated insignificant decay over freeze-thaw cycle. Comparison with cTnI assay showed excellent correlation (range: 8.0–3535.0 ng/L, R(2) = 0.9996). Reference intervals: The upper 95(th) and 99(th) percentile of the hscTnT population distribution were 6.8 and 16.2 ng/L in Non-Competition Horses, and 14.0 and 23.2 ng/L in Racing-Thoroughbreds. Between-breed, diurnal effect, and between-day variation was below LoQ. Two clinical cases with presumed cardiac pathology had hscTnT levels of 220.9 ng/L and 5723.0 ng/L. CONCLUSIONS: This benchmark study is the first to comply with CLSI guidelines, thus further establishing the performance characteristics of the hscTnT assay, and reference intervals in healthy horses. Two clinical cases demonstrated further the clinical utility of the assay. BioMed Central 2016-06-13 /pmc/articles/PMC4906598/ /pubmed/27296016 http://dx.doi.org/10.1186/s12917-016-0737-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Shields, E.
Seiden-Long, I.
Massie, S.
Passante, S.
Leguillette, R.
Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses
title Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses
title_full Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses
title_fullStr Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses
title_full_unstemmed Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses
title_short Analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-T assay in horses
title_sort analytical validation and establishment of reference intervals for a ‘high-sensitivity’ cardiac troponin-t assay in horses
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906598/
https://www.ncbi.nlm.nih.gov/pubmed/27296016
http://dx.doi.org/10.1186/s12917-016-0737-1
work_keys_str_mv AT shieldse analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses
AT seidenlongi analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses
AT massies analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses
AT passantes analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses
AT leguilletter analyticalvalidationandestablishmentofreferenceintervalsforahighsensitivitycardiactroponintassayinhorses